Densitas has launched the intelliRisk platform, its latest solution for high-risk breast cancer patient management.
This new platform joins the company’s existing solutions, intelliMammo and intelliMaven.
It offers a cohesive approach to patient and population health management across the diagnostic, screening, prevention, and treatment pathways for breast cancer.
With intelliRisk, healthcare providers will be able to identify, evaluate and manage high-risk patients, incorporating guidelines and recommendations for clinical decision-making customised to individual women.
It is available as a standalone web application or integrated with electronic health record (EHR) systems and provides guidance on personalised screening along with patient management workflows.
The solution aims to streamline provider workflows while enhancing outcomes for breast cancer patients and empowers healthcare professionals in breast imaging, genetics, oncology and population health by optimising the management of workflows.
Densitas CEO Mo Abdolell said: "As the demand for more integrated and efficient solutions in mammography practices grows, we are thrilled to introduce intelliRisk, our advanced breast cancer risk and high-risk patient management platform.
"Our customers have expressed a clear desire for a comprehensive solution for breast cancer risk, breast density, and MQSA EQUIP and Accreditation workflows from a single vendor.”
intelliRisk supports the assessment of lifetime breast cancer risk and management of high-risk patients through quality, efficiency, compliance and sustainability.
By providing precise risk assessments, it ensures tailored treatment plans for the unique risk profile of each patient.
The solution’s streamlined data integration allows quick access to risk insights, facilitating coordinated decision-making in patient management.
It also assists healthcare providers in meeting clinical guidelines by offering a structured approach for identifying, monitoring and documenting patients at high risk.
Additionally, the platform prioritises proactive patient management to optimise resource allocation.
